The National Health Service remains the sacred cow of British politics – any criticism is considered beyond the pale, guaranteed to trigger angry responses and accusations of bad faith. This book argues that the NHS should not be insulated from reasoned debate. In terms of health outcomes, it is one of the worst systems in the developed world, well behind those of other high-income countries. The NHS does achieve universal access to healthcare, but so do the health systems in every other developed country (with the exception of the US). Britain is far from being the only country where access to healthcare does not depend on an individual’s ability to pay. Author Kristian Niemietz draws on a wealth of international evidence to develop a vision for a universal healthcare system based on consumer sovereignty, freedom of choice, competition and pluralism. His roadmap for reform charts a path from the status quo to a more desirable and effective alternative.

A practical, succinct guide to the major health systems around the world and what lessons can be drawn from each about improving health worldwide. The essays are designed to give the reader essential knowledge of the history, strengths, weaknesses and lessons of each health system.

Antimicrobial resistance (AMR) is a large and growing problem with the potential for enormous health and economic consequences, globally. As such, AMR has become a central issue at the top of the public health agenda of OECD countries and beyond. In this

This report provides the first-ever comparative analysis of the role and performance of private health insurance (PHI) in OECD countries. It analyses PHI markets and identifies policy issues arising from their interdependence with publicly financed health coverage schemes. The report assesses the impact of PHI against health policy objectives, paying special attention to the challenges and benefits associated with different insurance mixes. The analysis identifies strengths as well as areas where private health insurance might pose challenges to health system performance. This report shows how governments can help ensure that PHI markets make a positive contribution to the performance of health systems. Examples of useful practices for developing more efficient and equitable health insurance markets are also presented.

How can health services in the UK and Europe be improved? And can costs be reduced at the same time? Over the years, many ideas have been put forward – from increased spending on preventive healthcare to the better use of technology to reduce bureaucracy and ‘pay for performance’ schemes. But author Nima Sanandaji says this is merely tinkering at the margins. What’s needed, he argues, is a completely new approach – one which embraces disruptive innovations from a new breed of entrepreneurs. Allowing true entrepreneurialism in healthcare might be considered extreme in a Western setting – but he points to a spectacular wave of success in the East to support his case. In India, Thailand, China and the Middle East, entrepreneurs have drawn inspiration from the motor industry to streamline procedures and create economies of scale. In areas such as heart surgery, they’ve dramatically driven down costs – and dramatically improved outcomes. So much so that the new market economies of the East are now, he contends, many steps of ahead of the West. In The Henry Fords of Healthcare Sanandaji outlines the lessons the West can now learn from the East, making a radical, compelling and controversial contribution to the debate on our own ailing health systems.

The objectives of this study are to describe experiences in price setting and how pricing has been used to attain better coverage, quality, financial protection, and health outcomes. It builds on newly commissioned case studies and lessons learned in calculating prices, negotiating with providers, and monitoring changes. Recognising that no single model is applicable to all settings, the study aimed to generate best practices and identify areas for future research, particularly in low- and middle-income settings. The report and the case studies were jointly developed by the OECD and the WHO Centre for Health Development in Kobe (Japan).